Page last updated: 2024-10-22

amifostine anhydrous and Anorexia

amifostine anhydrous has been researched along with Anorexia in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raza, A1
Qawi, H1
Lisak, L1
Andric, T1
Dar, S1
Andrews, C1
Venugopal, P1
Gezer, S1
Gregory, S1
Loew, J1
Robin, E1
Rifkin, S1
Hsu, WT1
Huang, RW1

Other Studies

1 other study available for amifostine anhydrous and Anorexia

ArticleYear
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols

2000